Dextroamphetamine sulfate is the dextrorotatory enantiomer of amphetamine, a central nervous system stimulant indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy.… Read more
Dextroamphetamine sulfate is the dextrorotatory enantiomer of amphetamine, a central nervous system stimulant indicated for the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. This category provides essential pharmaceutical reference standards required for the comprehensive quality control and impurity profiling of this active pharmaceutical ingredient. Laboratories utilize these high-purity materials, including pharmacopeial and non-pharmacopeial impurities such as 2-methyl-3-phenylaziridine and related adducts, to develop and validate analytical methods. By facilitating the accurate identification and quantification of degradation products and synthetic by-products, these reference compounds support regulatory compliance and ensure product safety. Whether performing routine batch analysis or investigating complex reaction mechanisms, access to well-characterized impurities and stable isotope labelled versions of the parent drug is critical for maintaining rigorous analytical standards throughout the pharmaceutical development lifecycle.